EU Gives $88 Million to CureVac to Ramp Up COVID-19 Vaccine
EU Gives $88 Million to CureVac to Ramp Up COVID-19 Vaccine
GALWAY, IRELAND--April 1, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Union (EU) has offered up to 80 million euro ($88 million) to German vaccine developer CureVac to scale up development and production of a vaccine against the Coronavirus in Europe.
Within this article: Details investment, proposed vaccine, controversy over alleged U.S. offer, related Coronavirus R&D and alliances
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market